RMM
Europe, Oost-Vlaanderen, Belgium, Gent
Description
RMM is Rudi M. Mariën's investment vehicle and focuses on biotechnology
Investor Profile
RMM has made 9 investments, with 0 in the past 12 months and 44% as lead.
Stage Focus
- Series C (33%)
- Series B (22%)
- Series E (11%)
- Series A (11%)
- Series Unknown (11%)
- Series D (11%)
Country Focus
- United States (44%)
- Switzerland (22%)
- Belgium (22%)
- Ireland (11%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Industry Focus
- Medical Device
- Manufacturing
- Biotechnology
- Health Care
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
'/%3e%3cuse xlink:href='%23a' transform='rotate(-90)'/%3e%3cuse xlink:href='%23a' transform='rotate(180)'/%3e%3c/svg%3e)
